Literature DB >> 2109001

In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse.

D Bernstein1, G Schiff, G Echler, A Prince, M Feller, W Briner.   

Abstract

The purpose of this work was to assess the in vitro antiviral effectiveness of a mouthrinse (Peridex) containing 0.12% chlorhexidine gluconate (CH) on several viruses that are associated with the oral cavity. These included herpes simplex virus (HSV), cytomegalovirus (CMV), influenza A, parainfluenza, polio, and hepatitis B (HBV). Virucidal assays in tissue cultures were performed on all viruses except HBV. The virucidal effect on HBV was assessed by inactivation of the DNA polymerase contained within the Dane particle of HBV. The CH mouthrinse had virucidal activity against all of the viruses, except polio, in as little as 30 s. The virucidal activity increased with time. However, there were differences in the responses of these viruses to the challenge of the CH mouthrinse, probably due to subtle differences in the physical/chemical structures of the virus envelopes. Results on DNA polymerase of the HBV virus were similar to those on the other viruses, except polio, suggesting a common mechanism. With respect to this mechanism, it was proposed that CH exerted its antiviral effect on the envelopes of these viruses, and that the absence of an envelope on polio precluded effectiveness against this virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109001     DOI: 10.1177/00220345900690030901

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  30 in total

1.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

2.  Deployment of a dental treatment facility during Operation Gritrock - lessons for future maritime contingency operations.

Authors:  B Mair
Journal:  Br Dent J       Date:  2015-05-22       Impact factor: 1.626

3.  Efficacy of antimicrobial and anti-viral coated air filters to prevent the spread of airborne pathogens.

Authors:  Rowan Watson; Morwenna Oldfield; Jack A Bryant; Lily Riordan; Harriet J Hill; Julie A Watts; Morgan R Alexander; Michael J Cox; Zania Stamataki; David J Scurr; Felicity de Cogan
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

Review 4.  Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).

Authors:  Victor B Hsue; Kyohei Itamura; Arthur W Wu; Elisa A Illing; Kevin J Sokoloski; Bree A Weaver; Benjamin P Anthony; Nathan Hughes; Jonathan Y Ting; Thomas S Higgins
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Sanitizing agents for virus inactivation and disinfection.

Authors:  Qianyu Lin; Jason Y C Lim; Kun Xue; Pek Yin Michelle Yew; Cally Owh; Pei Lin Chee; Xian Jun Loh
Journal:  View (Beijing)       Date:  2020-05-24

6.  Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.

Authors:  Fernanda de Paula Eduardo; Luciana Corrêa; Debora Heller; Carlo Amorin Daep; Carlos Benitez; Zilson Malheiros; Bernal Stewart; Maria Ryan; Clarisse Martins Machado; Nelson Hamerschlak; João Renato Rebello Pinho; Letícia Mello Bezinelli
Journal:  Heliyon       Date:  2021-06-18

7.  Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.

Authors:  Martin J Burton; Janet E Clarkson; Beatriz Goulao; Anne-Marie Glenny; Andrew J McBain; Anne Gm Schilder; Katie E Webster; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2020-09-16

8.  Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures (AGPs) on patients without suspected or confirmed COVID-19 infection.

Authors:  Martin J Burton; Janet E Clarkson; Beatriz Goulao; Anne-Marie Glenny; Andrew J McBain; Anne Gm Schilder; Katie E Webster; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2020-09-16

9.  Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.

Authors:  Martin J Burton; Janet E Clarkson; Beatriz Goulao; Anne-Marie Glenny; Andrew J McBain; Anne Gm Schilder; Katie E Webster; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2020-09-16

10.  Knowledge and attitude of dental students in Riyadh City toward the effect of mouthwashes on surface roughness and color stability of some esthetic restorations.

Authors:  Suliman Abdullah Alsulayhim; Khalid Hesham Alsaggaf; Munther Mohammed Al Eissa; Burhan Nezar Hamdi; Mohammed Abdulhamid Aljafar; Ahmed Altabbakh; Mazen Doumani
Journal:  J Family Med Prim Care       Date:  2021-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.